Dynamic42
The company develops and commercializes immunocompetent organ-on-chip models, including the DynamicOrgan system, which reproduces human organ functions such as vasculature and immune responses on biochips. They provide specialized kits for liver, gut, lung, and cancer research, alongside contract research services for toxicology screenings and lead optimization. Their products and services target pharmaceutical companies and research institutions seeking human-relevant data for preclinical drug testing and disease modeling.
Funding summary
- Total raised
- €0
- Funding rounds
- 1
Investors in Dynamic42
Investors on record for Dynamic42. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Dynamic42?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors